The Vallecas Project: A cohort to identify early markers and mechanisms of Alzheimer's disease

Frontiers in Aging Neuroscience

Volumn 7, Issue SEP, 2015, Pages

  Olazarán, Javier ^a   Valentí, Meritxell ^b   Belen Frades ^b   Zea Sevilla, María Ascensión ^b   Ávila Villanueva, Marina ^b   Fernández Blázquez, Miguel Ángel ^b   Calero, Miguel ^b   Dobato, José Luis ^b   Hernández Tamames, Juan Antonio ^c   León Salas, Beatriz ^b   Agüera Ortiz, Luis ^b   López Álvarez, Jorge ^b   Larrañaga, Pedro ^d   Bielza, Concha ^d   Álvarez Linera, Juan ^e   Martínez Martín, Pablo ^b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSIDAD REY JUAN CARLOS   (Spain)

^d UNIVERSIDAD POLITÉCNICA DE MADRID   (Spain)

^e HOSPITAL RUBER INTERNACIONAL   (Spain)

Author keywords

Alzheimer's disease; Cohort study; Early detection; Mild cognitive impairment; Risk factors

Indexed keywords

APOLIPOPROTEIN E4; BIOLOGICAL MARKER;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; COGNITION; COHORT ANALYSIS; FEMALE; FOLLOW UP; HETEROZYGOTE; HUMAN; LONGITUDINAL STUDY; MACHINE LEARNING; MALE; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY;

EID: 84946544803     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2015.00181     Document Type: Article

References (62)

1. Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., et al. (2011). The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 270-279. doi: 10.1016/j.jalz.2011.03.008.
2. American Psychiatric Association (APA). (2000). DSM-IV-TR. Barcelona: Masson.
3. Ashendorf, L., Vanderslice-Barr, J. L., and McCaffrey, R. J. (2009). Motor tests and cognition in healthy older adults. Appl. Neuropsychol. 5, 171-176. doi:10.1080/09084280903098562.
4. Barnes, D. E., Cenzer, I. S., Yaffe, K., Ritchie, C. S., and Lee, S. J. (2014). A point-based tool to predict conversion from mild cognitive impairment to probable Alzheimer's disease. Alzheimers Dement. 10, 646-655. doi:10.1016/j.jalz.2013.12.014.
5. Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., et al. (2012). Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N. Engl. J. Med. 30, 367(9):795-804. doi:10.1056/NEJMoa1202753.
6. Bermejo-Pareja, F., Benito-León, J., Vega, S., Medrano, M. J., and Román, G. C. (2008a). Incidence and subtypes of dementia in three elderly populations of central Spain. J. Neurol. Sci. 264, 63-72. doi:10.1016/j.jns.2007.07.021.
7. Bermejo-Pareja, F., Benito-León, J., Vega-Q, S., Díaz-Guzmán, J., Rivera-Navarro, J., Molina, J. A., et al. (2008b). The NEDICES cohort of the elderly. Methodology and main neurological findings. Rev. Neurol. 46, 416-423.
8. Brooks, L. G., and Loewenstein, D. A. (2010). Assessing the progression of mild cognitive impairment to Alzheimer's disease: current trends and future directions. Alzheimers Res. Ther. 29, 2(5):28. doi:10.1186/alzrt52.
9. Buschke, H. (1984). Cued recall in amnesia. J. Clin. Neuropsychol. 6, 433-440. doi:10.1080/01688638408401233.
10. Busse, A., Hensel, A., Gühne, U., Angermeyer, M. C., and Riedel-Heller, S. G. (2006). Mild cognitive impairment: long-term course of four clinical subtypes. Neurology 67, 2176-2185.
11. Cacho, J., García-García, R., Arcaya, J., Vicente, J. L., and Lantada, N. (1999). A proposal for application and scoring of the clock drawing test in Alzheimer's disease. Rev. Neurol. 1, 648-655.
12. Calero, O., Hortigüela, R., Bullido, M. J., and Calero, M. (2009). Apolipoprotein E genotyping method by real time PCR, a fast and cost-effective alternative to the TaqMan and FRET assays. J. Neurosci. Methods 15, 238-240. doi:10.1016/j.jneumeth.2009.06.033.
13. Carmona, P., Molina, M., Calero, M., Bermejo-Pareja, F., Martínez-Martín, P., and Toledano, A. (2013). Discrimination analysis of blood plasma associated with Alzheimer's disease using vibrational spectroscopy. J. Alzheimers Dis. 34, 911-920. doi:10.3233/JAD-122041.
14. Corrada, M. M., Paganini-Hill, A., Berlau, D. J., and Kawas, C. H. (2013). Apolipoprotein E genotype, dementia, and mortality in the oldest old: the 90+ Study. Alzheimers Dement. 9, 12-18. doi:10.1016/j.jalz.2011.12.004.
15. Del Barrio, J. L., Medrano, M. J., Arce, A., Bergareche, A., Bermejo, F., Díaz, J., et al. (2007). [Prevalence of vascular risk factors among Spanish populations aged 70 years and over, as reported in door-to-door studies on neurological diseases]. Neurologia 22, 138-146.
16. Dickerson, B. C., Wolk, D. A., and Alzheimer's Disease Neuroimaging Initiative. (2013). Biomarker-based prediction of progression in MCI: comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau. Front. Aging Neurosci. 5:55. doi:10.3389/fnagi.2013.00055.
17. Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., Dekosky, S. T., Barberger-Gateau, P., et al. (2010). Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol. 9, 1118-1127. doi:10.1016/S1474-4422(10)70223-4.
18. Dufouil, C., Fuhrer, R., and Alpérovitch, A. (2005). Subjective cognitive complaints and cognitive decline: consequence or predictor? The epidemiology of vascular aging study. J. Am. Geriatr. Soc. 53, 616-621. doi:10.1111/j.1532-5415.2005.53209.x.
19. Fernández-Blázquez, M. A., Ruiz-Sánchez de León, J. M., López-Pina, J. A., Llanero-Luque, M., Montenegro-Peña, M., and Montejo-Carrasco, P. (2012). A new shortened version of the Boston naming test for those aged over 65: an approach from item response theory. Rev. Neurol. 55(7):399-407.
20. Folstein, M. F., Folstein, S. E., and McHugh, P. R. (1975). "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189-198. doi:10.1016/0022-3956(75)90026-6.
21. Frisardi, V., Solfrizzi, V., Seripa, D., Capurso, C., Santamato, A., Sancarlo, D., et al. (2010). Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Res. Rev. 9, 399-417. doi:10.1016/j.arr.2010.04.007.
22. Garcia-Ptacek, S., Eriksdotter, M., Jelic, V., Porta-Etessam, J., Kåreholt, I., and Manzano Palomo, S. (2013). Subjective cognitive impairment: towards early identification of Alzheimer disease. Neurologia. doi:10.1016/j.nrl.2013.02.007.
23. Gauthier, S., Reisberg, B., Zaudig, M., Petersen, R. C., Ritchie, K., Broich, K., et al. (2006). Mild cognitive impairment. Lancet 367, 1262-1270.
24. Goodglass, H., and Kaplan, E. (1996). Assessment of Aphasia and Related Disorders. Madrid: Editorial Médica Panamericana. [Book in Spanish].
25. Hebert, L. E., Scherr, P. A., Beckett, L. A., Albert, M. S., Pilgrim, D. M., Chown, M. J., et al. (1995). Age-specific incidence of Alzheimer's disease in a community population. JAMA 3, 1354-1359. doi:10.1001/jama.273.17.1354.
26. Heister, D., Brewer, J. B., Magda, S., Blennow, K., McEvoy, L. K., and Alzheimer's Disease Neuroimaging Initiative. (2011). Predicting MCI outcome with clinically available MRI and CSF biomarkers. Neurology 25, 1619-1628. doi:10.1212/WNL.0b013e3182343314.
27. Jessen, F., Amariglio, R. E., van Boxtel, M., Breteler, M., Ceccaldi, M., Chételat, G., et al. (2014). A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement. 10, 844-852. doi:10.1016/j.jalz.2014.01.001.
28. Kaplan, E. F., Goodglass, H., and Weintraub, S. (1983). Boston Naming Test. Philadelphia, PA: Lea & Febiger.
29. Kukull, W. A., Higdon, R., Bowen, J. D., McCormick, W. C., Teri, L., Schellenberg, G. D., et al. (2002). Dementia and Alzheimer disease incidence: a prospective cohort study. Arch. Neurol. 59, 1737-1746. doi:10.1001/archneur.59.11.1737.
30. Lee, G. P., Loring, D. W., Newell, J., and McCloskey, L. (1994). Figural fluency on the five-point test: preliminary normative and validity data. Int. Neuropsychol. Soc. Program Abstr. 1, 51.
31. Luck, T., Luppa, M., Briel, S., and Riedel-Heller, S. G. (2010). Incidence of mild cognitive impairment: a systematic review. Dement. Geriatr. Cogn. Disord. 29, 164-175. doi:10.1159/000272424.
32. Manly, J. J., Bell-McGinty, S., Tang, M.-X., Schupf, N., Stern, Y., and Mayeux, R. (2005). Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch. Neurol. 62, 1739-1746. doi:10.1001/archneur.62.11.1739.
33. Mapstone, M., Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., et al. (2014). Plasma phospholipids identify antecedent memory impairment in older adults. Nat. Med. 20, 415-418. doi:10.1038/nm.3466.
34. McDowell, I. (2001). Alzheimer's disease: insights from epidemiology. Aging (Milano) 13, 143-162.
35. Mielke, M. M., Vemuri, P., and Rocca, W. A. (2014). Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences. Clin. Epidemiol. 6, 37-48. doi:10.2147/CLEP.S37929.
36. Morales, J. M., Bermejo, F. P., Benito-León, J., Rivera-Navarro, J., Trincado, R., Gabriel, S. R., et al. (2004). Methods and demographic findings of the baseline survey of the NEDICES cohort: a door-to-door survey of neurological disorders in three communities from Central Spain. Public Health 118, 426-433. doi:10.1016/j.puhe.2003.10.007.
37. Morris, J. C. (1993). The clinical dementia rating (CDR): current version and scoring rules. Neurology 43, 2412-2414. doi:10.1212/WNL.43.11.2412-a.
38. National Institute of Statistics. (2014). [Web page in Spanish]. Available at: www.ine.es.
39. Osorio, R. S., Pirraglia, E., Agüera-Ortiz, L. F., During, E. H., Sacks, H., Ayappa, I., et al. (2011). Greater risk of Alzheimer's disease in older adults with insomnia. J. Am. Geriatr. Soc. 59, 559-562. doi:10.1111/j.1532-5415.2010.03288.x.
40. Osterrieth, P. A. (1944). Le test de copie d'une figure complexe: contribution a l'étude de la perception et de la memoire. Arch. Psychol. 30, 286-356.
41. Peña-Casanova, J. (2005). Normalidad, semiología y patología neuropsicológicas. Programa Integrado de Exploración Neuropsicológica. Test Barcelona Revisado, 2nd Edn. Barcelona: Masson.
42. Peña-Casanova, J., Gramunt-Fombuena, N., Quiñones-Ubeda, S., Sánchez-Benavides, G., Aguilar, M., Badenes, D., et al. (2009a). Spanish Multicenter Normative Studies (NEURONORMA Project): norms for the Rey-Osterrieth complex figure (copy and memory), and free and cued selective reminding test. Arch. Clin. Neuropsychol. 24, 371-393. doi:10.1093/arclin/acp041.
43. Peña-Casanova, J., Quiñones-Ubeda, S., Gramunt-Fombuena, N., Quintana-Aparicio, M., Aguilar, M., Badenes, D., et al. (2009b). Spanish Multicenter Normative Studies (NEURONORMA Project): norms for verbal fluency tests. Arch. Clin. Neuropsychol. 24, 395-411. doi:10.1093/arclin/acp042.
44. Petersen, R. C., Roberts, R. O., Knopman, D. S., Boeve, B. F., Geda, Y. E., Ivnik, R. J., et al. (2009). Mild cognitive impairment: ten years later. Arch. Neurol. 66, 1447-1455. doi:10.1001/archneurol.2009.266.
45. Petersen, R. C., Roberts, R. O., Knopman, D. S., Geda, Y. E., Cha, R. H., Pankratz, V. S., et al. (2010). Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging. Neurology 7, 889-897. doi:10.1212/WNL.0b013e3181f11d85.
46. Pfeffer, R. I., Kurosaki, T. T., Harrah, C. H., Chance, J. M., and Filos, S. (1982). Measurement of functional activities in older adults in the community. J. Gerontol. 37, 323-329. doi:10.1093/geronj/37.3.323.
47. Podsiadlo, D., and Richardson, S. (1991). The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J. Am. Geriatr. Soc. 39, 142-148. doi:10.1111/j.1532-5415.1991.tb01616.x.
48. Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., and Ferri, C. P. (2013). The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 9, 63.e-75.e. doi:10.1016/j.jalz.2012.11.007.
49. Ravaglia, G., Forti, P., Montesi, F., Lucicesare, A., Pisacane, N., Rietti, E., et al. (2008). Mild cognitive impairment: epidemiology and dementia risk in an elderly Italian population. J. Am. Geriatr. Soc. 56, 51-58. doi:10.1111/j.1532-5415.2007.01503.x.
50. Regard, M., Strauss, E., and Knapp, P. (1982). Children's production on verbal and non-verbal fluency tasks. Percept. Mot. Skills 55(3 Pt 1), 839-844. doi:10.2466/pms.1982.55.3.839.
51. Reisberg, B., and Gauthier, S. (2008). Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. Int. Psychogeriatr. 20, 1-16.
52. Rey, A. (1941). L'examen psychologique dans les cas d'encephalopathie traumatique. Arch. Psychol. 28, 286-340.
53. Smith, A. D., and Yaffe, K. (2014). Dementia (including Alzheimer's disease) can be prevented: statement supported by international experts. J. Alzheimers Dis. 38, 699-703. doi:10.3233/JAD-132372.
54. Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., et al. (2011). Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 280-292. doi:10.1016/j.jalz.2011.03.003.
55. Spielberger, C. D., Gorsuch, R. L., and Lushene, R. E. (1970). Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.
56. Sunderland, A., Harris, J. E., and Gleave, J. (1984). Memory failures in everyday life following severe head injury. J. Clin. Neuropsychol. 6, 127-142. doi:10.1080/01688638408401204.
57. Ward, A., Tardiff, S., Dye, C., and Arrighi, H. M. (2013). Rate of conversion from prodromal Alzheimer's disease to Alzheimer's dementia: a systematic review of the literature. Dement. Geriatr. Cogn. Disord. Extra 3, 320-332. doi:10.1159/000354370.
58. Wechsler, D. (1997). Wechsler Adult Intelligence Scale-III. San Antonio, TX: The Psychological Corporation.
59. Weiner, M. W., Aisen, P. S., Jack, C. R., Jagust, W. J., Trojanowski, J. Q., Shaw, L., et al. (2010). The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement. 6, 202.e-211.e. doi:10.1016/j.jalz.2010.03.007.
60. Wimo, A., Jönsson, L., Bond, J., Prince, M., Winblad, B., and Alzheimer Disease International. (2013). The worldwide economic impact of dementia 2010. Alzheimers Dement. 9, 1.e-11.e. doi:10.1016/j.jalz.2012.11.006.
61. Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L.-O., et al. (2004). Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J. Intern. Med. 256, 240-246. doi:10.1111/j.1365-2796.2004.01380.x.
62. Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., et al. (1982-1983). Development and validation of a geriatric depression screening scale: a preliminary report. J. Psychiatr. Res. 17, 37-49. doi:10.1016/0022-3956(82)90033-4.